Enzo Biochem, Inc. ($0.01 Par Value) (ENZ): Price and Financial Metrics


Enzo Biochem, Inc. ($0.01 Par Value) (ENZ)

Today's Latest Price: $3.20 USD

0.16 (5.26%)

Updated Jan 19 7:00pm

Add ENZ to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 64 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

ENZ Stock Summary

  • ENZ has a higher market value than merely 22.85% of US stocks; more precisely, its current market capitalization is $145,600,952.
  • ENZ's went public 35.07 years ago, making it older than 92.86% of listed US stocks we're tracking.
  • Over the past twelve months, ENZ has reported earnings growth of 10,479.19%, putting it ahead of 99.93% of US stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Enzo Biochem Inc are BCOR, EHTH, TAOP, SWIR, and BBU.
  • ENZ's SEC filings can be seen here. And to visit Enzo Biochem Inc's official web site, go to www.enzo.com.

ENZ Stock Price Chart Interactive Chart >

Price chart for ENZ

ENZ Price/Volume Stats

Current price $3.20 52-week high $4.85
Prev. close $3.04 52-week low $1.56
Day low $2.92 Volume 560,700
Day high $3.23 Avg. volume 396,345
50-day MA $2.35 Dividend yield N/A
200-day MA $2.40 Market Cap 153.26M

Enzo Biochem, Inc. ($0.01 Par Value) (ENZ) Company Bio


Enzo Biochem, Inc. engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company was founded in 1976 and is based in New York, New York.


ENZ Latest News Stream


Event/Time News Detail
Loading, please wait...

ENZ Latest Social Stream


Loading social stream, please wait...

View Full ENZ Social Stream

Latest ENZ News From Around the Web

Below are the latest news stories about Enzo Biochem Inc that investors may wish to consider to help them evaluate ENZ as an investment opportunity.

Board Directors Stopping the Steal? Enzo Biochem Flouts Shareholder Democracy

By John Jannarone It didn’t work in Washington, but some companies continue to believe that ignoring the outcome of a vote might be acceptable on Wall Street. The latest unfortunate example is Enzo Biochem, Inc., a company founded in the 1970s that has frustrated investors with a poor operational and share-price performance over the last […]

Yahoo | January 15, 2021

Roumell Announces Preliminary Annual Meeting Results for Enzo Biochem, Inc.

Roumell Asset Management, LLC ("Roumell"), which owns 5.78% of the outstanding shares of common stock (the "Common Stock") of Enzo Biochem, Inc. (NYSE: ENZ) ("Enzo" or "the Company"), today announced the preliminary results at the Company's annual meeting of shareholders held on January 4, 2021 (the "Annual Meeting") based on the tally by Roumell's proxy solicitor.

Yahoo | January 5, 2021

ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT

NEW YORK, NY, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “The Company”), a leading biosciences and diagnostics company, today announced that it will participate in the 10th Annual LifeSci Partners Corporate Access Event, January 6-8 and 11-14, 2021 in concurrence with J.P. Morgan’s 39th Annual Healthcare Conference.Barry Weiner, President, and David Bench, Chief Financial Officer, will host virtual 1x1 meetings during both sessions of the event as well as present a corporate update on Wednesday, January 6th at 1pm EST.  To register or to listen to the presentation as well as to request a meeting, please visit the following registration link: http://lifesci.events/LifeSci2021About Enzo Biochem   Enzo Biochem is a pioneer in molecular diagnostics, leading...

Yahoo | January 5, 2021

ENZO BIOCHEM RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR TESTING POOLED SAMPLES ON THREE PLATFORMS INCLUDING COMPANY’S GENFLEX™ PROPRIETARY SYSTEM FOR DETECTION OF CORONAVIRUS SARS-CoV-2

\- Use of pooled sampling with Enzo’s molecular diagnostic technology can help rapidly expand the number of people tested for COVID-19 -NEW YORK, NY, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “The Company”), a leading biosciences and diagnostics company, announced today that it has received an expansion of its Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) authorizing the use of pooled samples containing up to five individual swab specimens with the Company’s AMPIPROBE® SARS-Cov-2 Test System utilizing tests on three different platforms including Enzo’s proprietary GENFLEX™ automated high-throughput platform.“This expansion of the EUA to include pooled samples can rapidly expand testing capacity based on ENZO’s proven,...

Yahoo | January 4, 2021

ENZO RESPONDS AFTER REVIEWING THE POSITION OF INSTITUTIONAL SHAREHOLDER SERVICES

NEW YORK, NY, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “The Company”), a leading biosciences and diagnostics company, announced today that it has reviewed the position of Institutional Shareholder Services (“ISS”) regarding the Company's executive compensation approach for the fiscal year ended July 31, 2020. To acknowledge and address the issues within the ISS report, Dr. Elazar Rabbani, the Company’s Chairperson and CEO, has requested the Compensation Committee of the Company’s Board of Directors not to pay his previously announced bonus in cash. In lieu thereof, he has requested such bonus be paid in common stock of Enzo based on the closing price of the Company’s shares on the date of issuance. Mr. Barry Weiner, the Company’s President, followed Dr....

Yahoo | December 28, 2020

Read More 'ENZ' Stories Here

ENZ Price Returns

1-mo 37.34%
3-mo 61.62%
6-mo 29.03%
1-year N/A
3-year -59.80%
5-year -29.82%
YTD 26.98%
2020 -4.18%
2019 -5.40%
2018 -65.89%
2017 17.44%
2016 54.22%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8084 seconds.